The current phase I R21 study has accomplished three Specific Aims. The feasibility of retrieval/extraction of protein, RNA, and DNA from archival formalin-paraffin tissues by modified Antigen Retrieval (AR) methods was demonstrated. PCR based methods were adapted and applied successfully for the amplification and quantitation of RNA/DNA extracted by modified AR from formalin-paraffin tissues. Three model systems were developed to monitor the efficacy of the modified AR process, including novel simulated or 'faux tissues' and purified 'protein matrix pellets'. Continuation of these studies in this R33 proposal focuses upon the incorporation of these advances into an 'integrated systems approach' to the molecular analysis of cancer tissues that have been preserved as formalin-paraffin blocks. Currently, immunohistochemical (IHC), in situ hybridization (ISH) and PCR based assays are widely applied to formalin-paraffin cancer tissues in 'routine diagnosis' and in basic cancer research, but the reproducibility and the validity of the findings are open to serious question due to the lack of uniform methods, in particular the total lack of 'standard reference materials', which are considered essential to the use of analogous methods in the diagnostic clinical laboratory. This proposal addresses pre-analytical, analytical, and post-analytical aspects of the use of IHC, ISH and PCR based assays as applied to formalin-paraffin cancer tissues. Integral to this approach is the development of reference standards for key analytes that are, or may be, employed as cancer or prognostic markers, against which results obtained by the analysis of formalin-paraffin cancer tissues will be calibrated to yield strict quantitative findings for diagnostic and research purposes. To meet the goal of objective quantitation in tissue sections, spectral image analysis will be performed at the USC Image Core, for which we have shown the feasibility of quantitative analysis of up to four different analytes simultaneously in the same formalin-paraffin section. This proposal is multi-disciplinary, including collaborations with the USC Cellular Imaging Core at Childrens Hospital of Los Angeles, the Huntington Medical Research Institute in Pasadena, Roche Molecular Systems Inc., the National Institute of Standards and Technology (NIST), and the University of California, San Francisco.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants Phase II (R33)
Project #
5R33CA103455-02
Application #
6794088
Study Section
Special Emphasis Panel (ZCA1-SRRB-C (M1))
Program Officer
Bledsoe, Marianna
Project Start
2003-09-01
Project End
2006-08-31
Budget Start
2004-09-07
Budget End
2005-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$591,063
Indirect Cost
Name
University of Southern California
Department
Pathology
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Yaziji, Hadi; Taylor, Clive R (2017) PD-L1 Assessment for Targeted Therapy Testing in Cancer: Urgent Need For Realistic Economic and Practice Expectations. Appl Immunohistochem Mol Morphol 25:1-3
Gu, Jiang; Taylor, Clive R (2014) Practicing pathology in the era of big data and personalized medicine. Appl Immunohistochem Mol Morphol 22:1-9
Taylor, Clive R (2014) Predictive biomarkers and companion diagnostics. The future of immunohistochemistry: ""in situ proteomics,"" or just a ""stain""? Appl Immunohistochem Mol Morphol 22:555-61
Torlakovic, Emina E; Francis, Glenn; Garratt, John et al. (2014) Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel. Appl Immunohistochem Mol Morphol 22:241-52
Bartsch, Georg; Mitra, Anirban P; Cote, Richard J (2010) Expression profiling for bladder cancer: strategies to uncover prognostic factors. Expert Rev Anticancer Ther 10:1945-54
Shi, Shan-Rong; Liu, Cheng; Pootrakul, Llana et al. (2008) Evaluation of the value of frozen tissue section used as ""gold standard"" for immunohistochemistry. Am J Clin Pathol 129:358-66
Shi, Shan-rong; Shi, Yan; Taylor, Clive R (2007) [Updates on antigen retrieval techniques for immunohistochemistry] Zhonghua Bing Li Xue Za Zhi 36:7-10
Birkhahn, Marc; Mitra, Anirban P; Cote, Richard J (2007) Molecular markers for bladder cancer: the road to a multimarker approach. Expert Rev Anticancer Ther 7:1717-27
Mitra, Anirban P; Birkhahn, Marc; Cote, Richard J (2007) p53 and retinoblastoma pathways in bladder cancer. World J Urol 25:563-71
Shi, S R; Liu, C; Young, L et al. (2007) Development of an optimal antigen retrieval protocol for immunohistochemistry of retinoblastoma protein (pRB) in formalin fixed, paraffin sections based on comparison of different methods. Biotech Histochem 82:301-9

Showing the most recent 10 out of 19 publications